Analyst
Berenberg
Equibles does not estimate personal net worth.
Beatrice Fairbairn is recorded as Analyst at Berenberg. Beatrice Fairbairn has spoken on 2 earnings calls and 1 other investor event across 3 companies, most recently for Ottobock SE & Co. KGaA on August 13, 2026. Those appearances were for Ottobock SE & Co. KGaA, Ottobock SE & Co. KGaA (OBOCY) and HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY. The companies whose calls Beatrice Fairbairn spoke on are classified in the Healthcare sector.
“I just had a couple on the kind of growth side of things. So firstly, could you specify how much of the B2B growth was impacted by these kind of special or timing effects that you've just mentioned?”
“I just had a couple on the kind of growth side of things. So firstly, could you specify how much of the B2B growth was impacted by these kind of special or timing effects that you've just mentioned?”
“I suppose could you give some more colour about how you're expected to contribute through the year and whether or not you still expect to kind of see a stronger 2027 in terms of this product?”
Berenberg
Analyst
Transcript header (unverified)
Ottobock SE & Co. KGaA
Medical Instruments & Supplies · Healthcare
OBOCY
Medical Instruments & Supplies · Healthcare
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Drug Manufacturers - Specialty & Generic · Healthcare
Publication Half-yearly Financial Report, Duderstadt
Ottobock SE & Co. KGaA
Trading update April 2026
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
